1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. FORTIS HEALTHCARE LTD.
Fortis Healthcare Ltd.
NSE: FORTIS | BSE: 532843

Fortis Healthcare Live Share Price Today, Share Analysis and Chart

BasketIn 5 Starfolio Baskets
aboutFortis Healthcare Ltd. is a major integrated healthcare provider in India, operating a network of multi-specialty hospitals and a diagnostic arm. The company provides a range of medical services from primary clinics to quaternary care. Its strategic ... Read More
Occupancy RateARPOB (Rev per Bed)
Ask AI about Fortis Healthcare
768.1513.25(1.76%)

26.77% Fall from 52W High

1.8M
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Acquisition
Fortis Healthcare buys 110-bed Suguna Hospital in Bengaluru for Rs 277 cr, expandable to 150 beds See details
Loading...
-
- / 100
39.5 / 100
Analyst Price Target
-

16

S

6

W

9

O

1

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

14Positive8Negative

Pass in checklist63.6%

045
55
100

PE Valuation Check

Right Now
Undervalued
8.5%
1 Year Forward
Undervalued
33.4%
INSIGHTFortis Healthcare is undervalued at both current PE and future earnings estimates.

Fortis Healthcare Stock Price Analysis

Day Price Range

1.8% 1 Day return
768.2 (LTP)
745768.2
LowHigh

Week Price Range

7.8% 1 Week return
768.2 (LTP)
705.4768.2
LowHigh

Month Price Range

-6.6% 1 Month return
768.2 (LTP)
705821
LowHigh

52 Week Price Range

-26.5% 1 Year return
768.2 (LTP)
7051,048.9
LowHigh
View full Price History/Seasonality

Fortis Healthcare Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Miss

Fortis Healthcare's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

CURRENT EPS
13.8
AVG. ESTIMATE
17.3
LOW ESTIMATE
15.9
HIGH ESTIMATE
18.4
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 25.1% in FY27

Consensus Recommendation

20 ANALYST Recommendations
STRONG BUY

The consensus recommendation from 20 analysts for Fortis Healthcare is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Fortis Healthcare Technical Analysis

Fortis Healthcare EMA & SMA

Neutral0
4 bullish, 4 bearish
Bullish4
Bearish4
5 Day753.3
10 Day749.9
12 Day751.5
20 Day764.7
26 Day776.7
50 Day817.6
100 Day860.3
200 Day878.5

Fortis Healthcare Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202664.6%
Week57.6%
Month53.6%

Fortis Healthcare Active Candlesticks

Closing Marubozu Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Fortis Healthcare Resistance and Support

760.43
Pivot
First Resistance775.9
Second Resistance783.6
Third Resistance799.0
First Support752.7
Second Support737.3
Third Support729.6
Day RSI46.5
Day MACD-25.2
Day MFI37.4
Day MACD Signal Line-32.9

Fortis Healthcare Beta

1 Month0.6
1 Year0.8
3 Month0.4
3 Year0.7

Fortis Healthcare Price Change Analysis

↓-6.6%
Over 1 Month
LowHigh
705.0821
↓-19.0%
Over 3 Months
LowHigh
705.0979.6
↓-17.9%
Over 6 Months
LowHigh
705.01010.1
↓-26.5%
Over 1 Year
LowHigh
705.01048.9
All Technicals →

Fortis Healthcare Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Northern Tk Venture Pte. Ltd.Promoter235,295,89531.2 %
Amansa Holdings Private LimitedFii11,764,8331.6 %
Rekha JhunjhunwalaPublic30,350,1524.0 %
Kotak Mahindra Trustee Co Ltd A/C Kotak Nifty MidcDii44,766,6945.9 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Fortis Healthcare Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.BulkSell24 Nov 2025921.935,281,102NSE
BNP PARIBAS FINANCIAL MARKETSBulkSell24 Nov 2025921.8511,938,263NSE
GOLDMAN SACHS BANK EUROPE SEBlockSell13 Nov 2025969.40399,348BSE
GOLDMAN SACHS BANK EUROPE SEBlockSell13 Nov 2025969.40176,393BSE
BNP PARIBAS FINANCIAL MARKETSBlockPurchase13 Nov 2025969.40399,348BSE
BNP PARIBAS FINANCIAL MARKETSBlockPurchase13 Nov 2025969.40176,393BSE
UBS AGBlockSell12 Nov 2025975.40509,235BSE
MORGAN STANLEY ASIA (SINGAPORE) PTE.BlockPurchase12 Nov 2025975.40509,235BSE
GOLDMAN SACHS (SINGAPORE) PTE - ODIBlockSell07 Oct 20251042219,013NSE
GOLDMAN SACHS BANK EUROPE SE - ODIBlockPurchase07 Oct 20251042219,013NSE
All deals
All insider trades

Fortis Healthcare Corporate Actions

Fortis Healthcare Dividend history and yield

Fortis Healthcare dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Fortis Healthcare dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
124 Jul 2026
1FINAL24 Jul 2026Equity Share
225 Jul 2025
1FINAL25 Jul 2025Equity Share
324 Jul 2024
1FINAL24 Jul 2024Equity Share
420 Jul 2023
1FINAL20 Jul 2023Equity Share

Fortis Healthcare Board Meetings

Fortis Healthcare past and upcoming board meetings.

#Ex-Date
PurposeNotes
105 Nov 2026
Quarterly Results & Others-
206 Aug 2026
Quarterly Results-
322 May 2026
Audited Results & Final Dividend-
413 Feb 2026
Quarterly Results-
511 Nov 2025
Quarterly Results-

Fortis Healthcare Rights issue

Fortis Healthcare rights issue history, along with record, ex-rights dates, and rights ratios.

#Ex-Date
RatioFace ValuePremiumRecord Date
118 Aug 2009
2.0:5.01010020 Aug 2009
All Corporate Actions

Fortis Healthcare Research Reports

Fortis Healthcare research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
105 Sep 2026ICICI Securities Limited1075905Buy18.78%-15.12%pdf
203 Sep 2026Motilal Oswal
Target
1130905Buy24.86%-15.12%pdf
308 Aug 2026ICICI Securities Limited
Reco
Target
1075955.15Buy12.55%-19.58%pdf
414 Jun 2026Geojit BNP Paribas
Target
1150980.15Buy17.33%-21.63%pdf
527 Feb 2026Axis Direct1038932.5Buy11.31%-17.62%pdf
All Reports of Fortis

Fortis Healthcare Corporate Filings

Fortis Healthcare BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
29 Oct 2026
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The relevant disclosure is attached
PDF
29 Oct 2026
Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Approval Of Un-Audited Financial Results And Other Matters
Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-audited financial results and other matters
PDF
28 Oct 2026
Fortis Healthcare Ltd - 532843 - Fortis Acquires 110-Bedded Suguna Hospital, Rajajinagar, Bengaluru For Approx. INR 277 Crs; Facility Provides Further Potential To Scale Up To 150 Beds
The relevant disclosure is attache.
PDF
28 Oct 2026
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
The relevant disclosure is attached.
PDF
28 Oct 2026
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Acquisition
The relevant disclosure is attached
PDF
VIEW ALL

Fortis Healthcare DocumentsAsk MarketMind AI

Fortis Healthcare Earnings Call

Fortis Healthcare earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Sep 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
11 Aug 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
07 Aug 2026Fortis Healthcare Results Earnings Call for Q1FY27AudioVideo
29 May 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
25 May 2026Fortis Healthcare Results Earnings Call for Q4FY26 & Full YearAudioVideo
view all

Fortis Healthcare Annual Reports

Fortis Healthcare financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link

Fortis Healthcare Credit Ratings

Fortis Healthcare credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
31 Aug 2025crisil ratingsFortis Hospitals LimitedFortis Hospitals Limited:Long-term rating upgraded to 'Crisil AA+/Stable'; short-term rating reaffirmedLink
29 Sep 2024crisil ratingsFortis Hospotel LimitedFortis Hospotel Limited:Ratings reaffirmed at 'CRISIL AA/Stable/CRISIL A1+'Link
29 Sep 2024crisil ratingsFortis Hospitals LimitedFortis Hospitals Limited:Ratings ReaffirmedLink
01 Apr 2024crisil ratingsFortis Hospotel LimitedFortis Hospotel Limited:Ratings reaffirmed at 'CRISIL AA/Stable/CRISIL A1+'; rated amount enhanced for Bank DebtLink
01 Apr 2024crisil ratingsFortis Hospitals LimitedFortis Hospitals Limited:Ratings reaffirmed at 'CRISIL AA/Stable/CRISIL A1+'; rated amount enhanced for Bank DebtLink

Fortis Healthcare Investor Presentations

Fortis Healthcare investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
06 Aug 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
22 May 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
13 Feb 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
08 Jan 2026Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
11 Nov 2025Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Fortis Healthcare - Company Profile

Fortis Healthcare Management Structure

Fortis Healthcare management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Ashutosh RaghuvanshiExecutive Director,Managing Director,Chief Executive Officer1030Mar 26
Mr. Vivek Kumar GoyalChief Financial Officer619Mar 26
Satyendra ChauhanCompany Secretary,Compliance Officer140Mar 26
Mr. Manu KapilaHead(Corparate Affairs,CSR,Assets)-Mar 26
Mr. Ajey MaharajHead(Corporate Communication.,PR.,Corporate Administration)-Mar 26
Ms. Richa S DebguptaChief Strategy Officer,Group Head(ESG),Business Head-Mar 26
Mr. Anil VinayakGroup Chief Operating Officer-Mar 26
Mr. Ranjan B PandeyChief Human Resources Officer-Mar 26
Mr. Prabhat KumarGroup General Counsel-Mar 26
Dr. Bishnu Prasad PanigrahiGroup Head-Mar 26
Mr. Bipin KumarChief Information Officer-Mar 26
Mr. Sanjay BawejaChief Internal Audit Officer(Risk Officer)-Mar 26
Dr. Ritu GargChief Growth Officer(Innovation)-Mar 26
Mr. Rajeev Kumar DuaVice President(Merger & Acquisitions)-Mar 26
Mr. Bidesh Chandra PaulGroup Head(Supply Chain Management)-Mar 26

Fortis Healthcare Board of Directors

Fortis Healthcare Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Ashutosh RaghuvanshiManaging Director & CEO1030.08Mar 26
Leo PuriChairman & Independent Directo207Mar 26
Satyendra ChauhanCompany Sec. & Compli. Officer140Mar 26
Indrajit BanerjeeIndependent Non Exe. Director101.5Mar 26
Suvalaxmi ChakrabortyIndependent Non Exe. Director91.5Mar 26
Ashok PanditNon-Exec & Non-Independent Dir20Mar 26
Prem Kumar NairVice Chairman11Mar 26
DILIP KADAMBINon-Exec & Non-Independent Dir10Mar 26
Keith Hsiu Chin LimNon-Exec & Non-Independent Dir5Mar 26
Mohd Shahazwan Bin Mohd HarrisNon-Exec & Non-Independent Dir-Mar 26
Website: www.fortishealthcare.com

About the company - Business Profile

Fortis Healthcare Ltd. is a major integrated healthcare provider in India, operating a network of multi-specialty hospitals and a diagnostic arm. The company provides a range of medical services from primary clinics to quaternary care. Its strategic position is supported by a partnership with its parent company, IHH Healthcare, which holds a controlling stake. The business is primarily divided into two segments: Healthcare Services (Hospitals) and Diagnostics (operating under the brand Agilus Diagnostics).

Key Points

  • Key Facts: Fortis Healthcare is headquartered in Gurugram, India. Its majority shareholder is IHH Healthcare (31.17% stake acquired in 2018). The company is listed on the BSE and NSE.
  • Operations and Resources: As of March 31, 2025, the company operated 27 hospitals (including JVs and O&M facilities) with approximately 4,750 operational beds. Its diagnostic business, Agilus Diagnostics, maintains over 400 centers, 3,900+ customer touchpoints, and 43 accredited labs across 25 states.
  • Ownership and Privatization: Following a significant fund infusion of ₹4,000 Crores by IHH Healthcare in 2018, the company stabilized its balance sheet and acquired the RHT Health Trust portfolio.
  • Market Significance: Fortis serves critical medical needs across oncology, gastroenterology, neurosciences, renal sciences, orthopedics, and cardiac sciences. These key specialties contributed 62% to hospital revenue in FY24.
  • Revenue Breakdown (FY2025 Annual Figures):
    • Total Revenue from Operations: ₹7,783 Crores.
    • Hospital Business: ₹6,528 Crores (84% of total revenue), showing a 14.8% YoY growth.
    • Diagnostics Business (Agilus): Contributed the remaining 16% of revenue.
    • Geographical Mix (H1FY26): North (31%), South (32%), West (20%), East (13%), and International (4%).
  • Business Model and Strengths: The company focuses on a hub-and-spoke model for diagnostics and a multi-specialty approach for hospitals. It excels in high-complexity surgical procedures, which drove a 9.0% growth in ARPOB (Average Revenue Per Occupied Bed).
  • Technology and Innovation:
    • Equipment: Deployed advanced medical technology including 1 MR LINAC, 10 LINACs, 11 Da Vinci Robots, 17 Ortho Robots, and 41 Cath Labs.
    • Digitalization: Implementation of water metering infrastructure (98% deployment) and robust patient feedback systems.
  • Partnerships and Acquisitions:
    • People Tree Hospital, Bangalore: Potential addition of ~300 beds (Dec '25).
    • Shrimann Superspecialty Hospital, Jalandhar: Potential ~450 beds (Jul '25).
    • O&M Agreement with Gleneagles: ~680 beds (Jul '25).
    • Agilus Consolidation: Consolidating stake in Agilus Diagnostics Ltd (Dec '24/Jan '25).
  • Employee Metrics: The group employs over 23,000 people. Notably, 55.8% of permanent employees are women, reflecting high gender diversity.
  • Strategic Initiatives and Outlook:
    • Bed Expansion: Planned capacity addition of 3,200+ beds from FY25 to FY30, targeting a total of 8,000+ beds.
    • Sustainability: Reduced energy consumption per occupied bed by 6.53% in FY25.
    • Portfolio Rationalization: Divested non-core assets like the Richmond Road facility in Bangalore (Dec '24) and Fortis Malar in Chennai (Feb '24).

References

  1. Annual Report May 2025
  2. Investor Presentation Jan 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024

Fortis Healthcare FAQ

Fortis Healthcare today is trading in the green, up by 1.76% at ₹768.15.
Fortis Healthcare is currently trading up 1.76% on an intraday basis. In the past week the stock rose 7.75%. Stock has been down 19.04% in the past quarter and fell 26.46% in the past year. You can view this in the share price history/seasonality section.
Fortis Healthcare is listed on NSE with the ticker FORTIS and on BSE as 532843. It's currently trading on NSE at a share price of ₹768.15 and on BSE with a share price of ₹769.8.
The market cap of Fortis Healthcare is ₹57,992.11 Cr. as of Oct 30, 2026.
Fortis Healthcare announced a FINAL dividend of 10% which equals ₹1 in Jul 24, 2026.The last three ex-dates for Fortis Healthcare were Jul 25, 2025, Jul 24, 2024 and Jul 20, 2023. To view the full dividend history of Fortis Healthcare click here.
Fortis Healthcare has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Fortis Healthcare reported ₹2,559.5 Cr. in revenue, ₹266.39 Cr. in net profit, and ₹561.12 Cr. in EBITD as of Aug 06, 2026 for Q1 FY26-27.
According to the predictions of 20 analysts, the share price prediction for Fortis Healthcare is ₹1,098.25 with an upside of 43%.
The PE ratio of Fortis Healthcare is 55.34 as of Oct 30, 2026.
The PB ratio of Fortis Healthcare is 5.71 as of Oct 30, 2026.
You can view the latest analyst reports on the Fortis Healthcare reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×